Suchergebnisse - Ignacio Matos
- Treffer 1 - 16 von 16
-
1
Agnostic-Histology Approval of New Drugs in Oncology: Are We Already There? von Cinta Hierro, Ignacio Matos, Juan Martin‐Liberal, María Ochoa de Olza, Elena Garralda
Veröffentlicht 2019Revisão -
2
-
3
-
4
Phase I, first-in-human study of futibatinib, a highly selective, irreversible FGFR1–4 inhibitor in patients with advanced solid tumors von Rastislav Bahleda, Funda Meric‐Bernstam, Lipika Goyal, Ben Tran, Yi He, Ikuo Yamamiya, Karim A. Benhadji, Ignacio Matos, Hendrik‐Tobias Arkenau
Veröffentlicht 2020Artigo -
5
-
6
Atuação do cirurgião dentista na prevenção de infecções respiratórias em pacientes nas unidades de terapia de terapia intensiva von Ignacio Matos, Thalita Medeiros Fernandes de Macêdo, Thiago Moreira, B. S. Lima, Camila Fagundes, Fábio Catão, Guilherme Oliveira de. Sousa, Gisele Cássia de Sousa, Heno Ferreira Lopes, Maria Reis
Veröffentlicht 2024Artigo -
7
Early evolutionary divergence between papillary and anaplastic thyroid cancers von J. Capdevila, Regina Mayor, Francesco M. Mancuso, Carmela Iglesias, Ginevra Caratù, Ignacio Matos, Carles Zafón, Jorge Hernando, A. Petit, Paolo Nucíforo, José Cameselle‐Teijeiro, Clara V. Álvarez, Juan A. Recio, Josep Tabernero, Xavier Matías‐Guiu, Ana Vivancos, Joan Seoane
Veröffentlicht 2018Artigo -
8
The PALBONET Trial: A Phase II Study of Palbociclib in Metastatic Grade 1 and 2 Pancreatic Neuroendocrine Tumors (GETNE-1407) von Enrique Grande, Àlex Teulé, Teresa Alonso‐Gordoa, Paula Jiménez‐Fonseca, Marta Benavent, Jaume Capdevila, Ana Custodio, Ruth Vera, Javier Munárriz, Adelaida La Casta, Juan J. Díez, Pablo Gajate, Javier Molina‐Cerrillo, Ignacio Matos, Eva Cristóbal, J.C. Ruffinelli, José Palacios, Rocio García‐Carbonero
Veröffentlicht 2020Artigo -
9
Analysis of mutant allele fractions in driver genes in colorectal cancer – biological and clinical insights von Rodrigo Dienstmann, Elena Élez, Guillem Argilés, Ignacio Matos, Enrique Sanz‐García, Carolina Ortiz, Teresa Macarulla, Jaume Capdevila, María Alsina, Tamara Saurí, Helena Verdaguer, Marta Vilaró, Fiorella Ruíz‐Pace, Cristina Viaplana, Ariadna García, Stefania Landolfi, Héctor G. Pálmer, Paolo Nucíforo, Jordi Rodón, Ana Vivancos, Josep Tabernero
Veröffentlicht 2017Artigo -
10
1913O Results from the registrational phase I/II ARROW trial of pralsetinib (BLU-667) in patients (pts) with advanced RET mutation-positive medullary thyroid cancer (RET+ MTC) von Mimi I. Hu, Vivek Subbiah, Lori J. Wirth, M Schuler, Aaron S. Mansfield, Marcia S. Brose, Giuseppe Curigliano, Sophie Leboulleux, Viola W. Zhu, Bhumsuk Keam, Ignacio Matos, C-C. Lin, D.R. Adkins, Christina S. Baik, G. Lopes, Yann Godbert, Debashis Sarker, H. Zhang, Christopher D. Turner, Matthew Taylor
Veröffentlicht 2020Artigo -
11
Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics von Maria Lozano-Rabella, Andrea García-Garijo, Jara Palomero, Anna Yuste-Estevanez, Florian Erhard, Roc Farriol-Duran, Juan Martín-Liberal, Maria Ochoa de Olza, Ignacio Matos, Jared J. Gartner, Michael Ghosh, Francesc Canals, August Vidal, Josep M. Piulats, Xavier Matías‐Guiu, Irene Braña, Eva Muñoz‐Couselo, Elena Garralda, Andreas Schlösser, Alena Gros
Veröffentlicht 2023Carta -
12
Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies von Hyun Cheol Chung, Sarina A. Piha‐Paul, José A. López-Martín, Jan H.M. Schellens, Steven Kao, Wilson H. Miller, Jean‐Pierre Delord, Bo Gao, David Planchard, Maya Gottfried, Alona Zer, Shadia I. Jalal, Nicolas Penel, Janice M. Mehnert, Ignacio Matos, Jaafar Bennouna, Dong‐Wan Kim, Lei Xu, Suba Krishnan, Kevin Norwood, Patrick A. Ott
Veröffentlicht 2019Artigo -
13
Capturing Hyperprogressive Disease with Immune-Checkpoint Inhibitors Using RECIST 1.1 Criteria von Ignacio Matos, Juan Martín-Liberal, Alonso García-Ruiz, Cinta Hierro, María Ochoa de Olza, Cristina Viaplana, Analía Azaro, María Vieito, Irene Braña, Gemma Mur, Javier Ros, José M. Mateos, Guillermo Villacampa, Roger Berché, Mafalda Oliveira, María Alsina, Elena Élez, Ana Oaknin, Eva Muñoz‐Couselo, Joan Carles, Enriqueta Felip, Jordi Rodón, Josep Tabernero, Rodrigo Dienstmann, Raquel Pérez-López, Elena Garralda
Veröffentlicht 2019Artigo -
14
Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509) von Jaume Capdevila, Nicola Fazio, Carlos López, Àlex Teulé, Juan W. Valle, Salvatore Tafuto, Ana Custodio, Nicholas S. Reed, Markus Raderer, Enrique Grande, Rocio García‐Carbonero, Paula Jiménez‐Fonseca, Jorge Hernando, Alberto Bongiovanni, Francesca Spada, Vicente Alonso, Lorenzo Antonuzzo, Andrea Spallanzani, Alfredo Berruti, Adelaida La Casta, Isabel Sevilla, Patrizia Kump, Dario Giuffrida, Xavier Merino, Lorena Marianne Villalobos Trejo, Pablo Gajate, Ignacio Matos, Ángela Lamarca, Toni Ibrahim
Veröffentlicht 2021Artigo -
15
A nomogram for predicting complications in patients with solid tumours and seemingly stable febrile neutropenia von Fonseca, Paula Jiménez, Carmona-Bayonas, Alberto, García, Ignacio Matos, Marcos, Rosana, Castañón, Eduardo, Antonio, Maite, Font, Carme, Biosca, Mercè, Blasco, Ana, Lozano, Rebeca, Ramchandani, Avinash, Beato, Carmen, de Castro, Eva Martínez, Espinosa, Javier, Martínez-García, Jerónimo, Ghanem, Ismael, Cubero, Jorge Hernando, Manrique, Isabel Aragón, Navalón, Francisco García, Sevillano, Elena, Manzano, Aránzazu, Virizuela, Juan, Garrido, Marcelo, Mondéjar, Rebeca, Arcusa, María Ángeles, Bonilla, Yaiza, Pérez, Quionia, Gallardo, Elena, del Carmen Soriano, Maria, Cardona, Mercè, Lasheras, Fernando Sánchez, Cruz, Juan Jesús, Ayala, Francisco
Veröffentlicht 2016Text -
16
PL02.08 Registrational Results of LIBRETTO-001: A Phase 1/2 Trial of LOXO-292 in Patients with RET Fusion-Positive Lung Cancers von Alexander Drilon, Geoffrey R. Oxnard, Lori J. Wirth, Benjamin Besse, Oliver Gautschi, Sichuang Tan, Herbert H. Loong, Todd M. Bauer, Yoon Jun Kim, Atsushi Horiike, K. Park, Manisha H. Shah, Caroline E. McCoach, Lyudmila Bazhenova, Takeshi Seto, Marcia S. Brose, Nathan A. Pennell, Jared Weiss, Ignacio Matos, Nir Peled, Byoung Chul Cho, Y. Ohe, Karen L. Reckamp, Valentina Boni, Miyako Satouchi, Gerald S. Falchook, Wallace Akerley, Haruko Daga, Tomohiro Sakamoto, Jyoti D. Patel, Nehal J. Lakhani, Fabrice Barlési, Mark E. Burkard, Viola W. Zhu, Víctor Moreno, Jacques Médioni, Marc Matrana, Christian Rolfo, D.H. Lee, Hovav Nechushtan, Melissa L. Johnson, Vamsidhar Velcheti, Matomo Nishio, Ryo Toyozawa, Kadoaki Ohashi, Lixin Song, Junyi Han, Alexander I. Spira, Filippo de Braud, Kristoffer Staal Rohrberg, Shinji Takeuchi, Jun Sakakibara, S. Waqar, Hirotsugu Kenmotsu, F. Perry Wilson, Bijay Nair, Elizabeth Olek, Jennifer Kherani, Kevin Ebata, Edward Y. Zhu, Mai Nguyen, Luxi Yang, Xin Huang, Scott Cruickshank, S. Michael Rothenberg, Benjamin Solomon, Ken Goto, Vivek Subbiah
Veröffentlicht 2019Artigo
Suchwerkzeuge:
Ähnliche Schlagworte
Medicine
Internal medicine
Oncology
Cancer
Biology
Cancer research
Clinical trial
Gastroenterology
Genetics
Immunotherapy
Phases of clinical research
Response Evaluation Criteria in Solid Tumors
Astrobiology
Chemotherapy
Colorectal cancer
Gene
Immune system
Immunology
Intensive care medicine
Neuroendocrine tumors
Pathology
Pharmacology
Physics
Progressive disease
Refractory (planetary science)
Surgery
Thyroid cancer
A549 cell
Adverse effect
Allele